logo-loader
NASDAQ:ALNY

Alnylam Pharmaceuticals

Receive alerts
Market:
NASDAQ
Price
147.18 USD
Day Change
-1.49%
Market Cap:
$19.77 b
52 weeks high
479.73
52 weeks low
146.54

In brief

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing therapeutics based on ribonucleic acid interface (RNAi). The RNAi therapeutic program, ALN-RSV01, is in Phase II clinical trials for the treatment of human respiratory syncytial virus (RSV), infection.